Literature DB >> 8710379

Tyrosine kinase inhibitor herbimycin A reduces the stability of cyclin-dependent kinase Cdk6 protein in T-cells.

T Akagi1, H Ono, K Shimotohno.   

Abstract

The Cdk6 protein level rapidly decreased after treatment with the tyrosine kinase inhibitor herbimycin A in human T-cell lines. This decrease is fairly specific, because the level of other Cdks such as Cdk2 and Cdk4 and cyclins such as cyclin D2, cyclin E and cyclin A, did not change significantly even after 24 h treatment with herbimycin A. Pulse-chase analysis revealed that the decrease in the Cdk6 protein level results from reduced stability of the protein. Our results suggest that herbimycin A-sensitive protein tyrosine kinase(s) are involved in the regulation of the Cdk6 protein level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710379

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1.

Authors:  I Matushansky; F Radparvar; A I Skoultchi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 2.  Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity.

Authors:  L Neckers; T W Schulte; E Mimnaugh
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia.

Authors:  M Chilosi; C Doglioni; Z Yan; M Lestani; F Menestrina; C Sorio; A Benedetti; F Vinante; G Pizzolo; G Inghirami
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.